Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective.
Shelley Elizabeth KeatingYogesh ChawlaArka DeElena S GeorgePublished in: Hepatology international (2024)
Large-scale multidisciplinary trials in people with MAFLD with long-term follow-up, that can be scaled up into mainstream healthcare, are required. Future management guidelines should consider the heterogeneity of MAFLD and specialised models of care that coordinate the health workforce to manage the increased and growing MAFLD population.
Keyphrases
- healthcare
- public health
- randomized controlled trial
- quality improvement
- metabolic syndrome
- single cell
- physical activity
- cardiovascular disease
- weight loss
- oxidative stress
- current status
- health information
- affordable care act
- fatty acid
- pain management
- risk assessment
- climate change
- social media
- health insurance
- chronic pain
- human health
- health promotion